{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:40Z","timestamp":1772165680599,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12083-y","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T10:34:09Z","timestamp":1763807649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of kidney function after five years of follow-up in a large Spanish cohort of patients with HIV: risk factors for progression"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-4961","authenticated-orcid":false,"given":"Rosa","family":"Fern\u00e1ndez Bonifacio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Cof\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Carles","family":"Trull\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Bedini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naira","family":"Rico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"12083_CR1","unstructured":"World Health Organization. HIV\/AIDS. 2020. Available: https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids (Last accessed 8 March 2025)."},{"issue":"9939","key":"12083_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","volume":"384","author":"CJ Smith","year":"2014","unstructured":"Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(14)60604-8.","journal-title":"Lancet"},{"issue":"9","key":"12083_CR3","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1093\/cid\/ciu617","volume":"59","author":"GM Lucas","year":"2014","unstructured":"Lucas GM, Ross MJ, Stock PG, et al. Association of the infectious diseases society of America. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;59(9):e96\u2013138. https:\/\/doi.org\/10.1093\/cid\/ciu617.","journal-title":"Clin Infect Dis"},{"key":"12083_CR4","doi-asserted-by":"publisher","unstructured":"Yazie TS, Shiferaw WS, Gebeyehu AA, Teshome AA, Addisu ZD, Belete AM. PLoS One. Chronic kidney disease among people living with HIV on TDF based regimen: a systematic review and meta-analysis. 2025;20(2):e0318068. https:\/\/doi.org\/10.1371\/journal.pone.0318068","DOI":"10.1371\/journal.pone.0318068"},{"key":"12083_CR5","doi-asserted-by":"publisher","unstructured":"Tenofovir-induced kidney. Disease: an acquired renal tubular mitochondriopathy Perazella. Mark Kidney Int. 2010;111060\u20133. https:\/\/doi.org\/10.1038\/ki.2010.344.","DOI":"10.1038\/ki.2010.344"},{"key":"12083_CR6","first-page":"1","volume":"40","author":"A Bertoldi","year":"2017","unstructured":"Bertoldi A, De Crignis E, Miserocchi A, et al. HIV and kidney: a dangerous liaison. Rev New Microbiol. 2017;40:1\u201310.","journal-title":"Rev New Microbiol"},{"issue":"9903","key":"12083_CR7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(13)61809-7.","journal-title":"Lancet"},{"issue":"4","key":"12083_CR8","doi-asserted-by":"publisher","first-page":"e0215575","DOI":"10.1371\/journal.pone.0215575","volume":"14","author":"RM Brito","year":"2019","unstructured":"Brito RM, Nguyen DT, Johnson JR, Lai EJ, Castro RE, Albert AM, Barnes AS, Graviss EA, Suki WN. Chronic kidney disease in patients infected with human immunodeficiency virus (HIV) in an urban cohort. PLoS ONE. 2019;14(4):e0215575. https:\/\/doi.org\/10.1371\/journal.pone.0215575.","journal-title":"PLoS ONE"},{"issue":"12","key":"12083_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1097\/QAD.0000000000003662","volume":"37","author":"H Gao","year":"2023","unstructured":"Gao H, Zhang J, Yang X, Chen S, Mathew R, Weissman S, Olatosi B, Li X. The incidence and dynamic risk factors of chronic kidney disease among people with HIV. AIDS. 2023;37(12):1783\u201390. https:\/\/doi.org\/10.1097\/QAD.0000000000003662.","journal-title":"AIDS"},{"key":"12083_CR10","doi-asserted-by":"publisher","unstructured":"Levin A. y cols. Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns. Kidney Int. 2024;105(4):684\u2013701. https:\/\/doi.org\/10.1016\/j.kint.2023.10.016","DOI":"10.1016\/j.kint.2023.10.016"},{"issue":"3","key":"12083_CR11","doi-asserted-by":"publisher","first-page":"0","DOI":"10.3265\/Nefrologia.pre2011.Jan.10807","volume":"3","author":"R Monta\u00f1\u00e9s","year":"2011","unstructured":"Monta\u00f1\u00e9s R, Gr\u00e0cia S, P\u00e9rez D. Consensus Document. Recommendations on assessing proteinuria during the diagnosis and follow-up of chronic kidney disease. Nefrologia. 2011;3(3):0\u2013378. https:\/\/doi.org\/10.3265\/Nefrologia.pre2011.Jan.10807.","journal-title":"Nefrologia"},{"key":"12083_CR12","doi-asserted-by":"publisher","unstructured":"Szczech LA, Gange SJ, Van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61(1):195\u2013202. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00094.x","DOI":"10.1046\/j.1523-1755.2002.00094.x"},{"key":"12083_CR13","doi-asserted-by":"publisher","unstructured":"Schrader SY, Zeder AJ, Hilge R, Bogner JR, Seybold U, et al. Medium-grade proteinuria is a risk factor for incident markers of chronic kidney disease. HIV Med. 2020;21(8):481\u2013491. https:\/\/doi.org\/10.1111\/hiv.12881. Epub 2020 Jun 17. PMID: 32558056.","DOI":"10.1111\/hiv.12881"},{"key":"12083_CR14","unstructured":"The ISN\u2013GKHA (ISN\u2013Global Kidney Health Atlas) 3rd Edition. 2023 Available: https:\/\/www.theisn.org\/initiatives\/global-kidney-health-atlas\/ (Last accessed: 4 April 2025)."},{"issue":"4","key":"12083_CR15","doi-asserted-by":"publisher","first-page":"e0195443","DOI":"10.1371\/journal.pone.0195443","volume":"13","author":"UE Ekrikpo","year":"2018","unstructured":"Ekrikpo UE, Kengne AP, Bello AK, et al. Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. PLoS ONE. 2018;13(4):e0195443. https:\/\/doi.org\/10.1371\/journal.pone.0195443.","journal-title":"PLoS ONE"},{"issue":"6","key":"12083_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/apc.2009.0326","volume":"24","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, Brodine S. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010;24(6):353\u201360. https:\/\/doi.org\/10.1089\/apc.2009.0326.","journal-title":"AIDS Patient Care STDS"},{"key":"12083_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3265\/Nefrologia.pre2009.Dic.5732","volume":"30","author":"A Otero","year":"2010","unstructured":"Otero A, de Francisco A, Gayoso P, Garc\u00eda F, on behalf of the EPIRCE Study Group. Prevalence of chronic renal disease in spain: results of the EPIRCE study. Nefrologia. 2010;30:78\u201386. https:\/\/doi.org\/10.3265\/Nefrologia.pre2009.Dic.5732.","journal-title":"Nefrologia"},{"key":"12083_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nefro.2018.04.004","volume":"38","author":"M Renal Gorostidi","year":"2018","unstructured":"Renal Gorostidi M, S\u00e1nchez-Mart\u00ednez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamar\u00eda R, del Pino MD, Guallar-Castill\u00f3n P, de \u00c1lvaro F, Rodr\u00edguez-Artalejo F, Banegas JR. Prevalencia de Enfermedad renal cr\u00f3nica En Espa\u00f1a: impacto de La acumulaci\u00f3n de factores de Riesgo cardiovascular. Nefrologia. 2018;38:606\u201315. https:\/\/doi.org\/10.1016\/j.nefro.2018.04.004.","journal-title":"Nefrologia"},{"issue":"1","key":"12083_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12882-024-03865-8","volume":"25","author":"EM Nasuuna","year":"2024","unstructured":"Nasuuna EM, Tomlinson LA, Kalyesubula R, Dziva Chikwari C, Castelnuovo B, Manabe YC, Nakanjako D, Weiss HA. Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or Cystatin C among young people living with HIV in Uganda. BMC Nephrol. 2024;25(1):422. https:\/\/doi.org\/10.1186\/s12882-024-03865-8.","journal-title":"BMC Nephrol"},{"key":"12083_CR20","doi-asserted-by":"publisher","unstructured":"Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21(18):2435\u201343. https:\/\/doi.org\/10.1097\/QAD.0b013e32827038ad.","DOI":"10.1097\/QAD.0b013e32827038ad"},{"issue":"7","key":"12083_CR21","doi-asserted-by":"publisher","first-page":"e090345","DOI":"10.1136\/bmjopen-2024-090345","volume":"15","author":"MD Abate","year":"2025","unstructured":"Abate MD, Kassa MA, Yilak G, Habtie TE, Temesgen D, Mulu B, Feleke SF, Baylie A, Bizuayehu MA. Incidence, progression and predictors of chronic kidney disease among adult HIV\/AIDS patients on antiretroviral treatment in comprehensive specialised hospitals in the Amhara Region, Ethiopia, 2022: a multi-centre retrospective follow-up study. BMJ Open. 2025;15(7):e090345. https:\/\/doi.org\/10.1136\/bmjopen-2024-090345.","journal-title":"BMJ Open"},{"issue":"9","key":"12083_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"12083_CR23","doi-asserted-by":"publisher","unstructured":"Wassner C, Bradley N, Lee Y. A review clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide. Int Assoc Provid J AIDS Care. 2020 Jan-Dec;19:2325958220919231. https:\/\/doi.org\/10.1177\/2325958220919231. PMID: 32295453; PMCID: PMC7163232.","DOI":"10.1177\/2325958220919231"},{"key":"12083_CR24","doi-asserted-by":"publisher","unstructured":"Zeder AJ, Hilge R, Schrader S, Bogner JR, Seybold U. Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate. Infection. 2016;44(5):641-9. https:\/\/doi.org\/10.1007\/s15010-016-0911-1. Epub 2016 Jun 2. PMID: 27256076.","DOI":"10.1007\/s15010-016-0911-1"},{"key":"12083_CR25","doi-asserted-by":"publisher","unstructured":"Domingo P, Suarez-Lozano I, Gutierrez F, Estrada V, Knobel H, Palacios R, Antela A, Blanco JR, Fulladosa X, VACH. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: results from the VACH longitudinal cohort study. Nefrologia (Engl Ed). 2019 Sep-Oct;39(5):497\u2013505. English, Spanish. https:\/\/doi.org\/10.1016\/j.nefro.2019.01.009","DOI":"10.1016\/j.nefro.2019.01.009"},{"key":"12083_CR26","unstructured":"United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2023."},{"key":"12083_CR27","doi-asserted-by":"publisher","unstructured":"Mocroft A, Lundgren JD, Ross M, et al. D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809. https:\/\/doi.org\/10.1371\/journal.pmed.1001809","DOI":"10.1371\/journal.pmed.1001809"},{"key":"12083_CR28","doi-asserted-by":"publisher","unstructured":"Cristelli MP, Trull\u00e0s JC, Cof\u00e1n F, Rico N, Manzardo C, Ambrosioni J, Bedini JL, Moreno A, Diekmann F, Miro JM, CKD-H. Clinical Investigators. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy. Braz J Infect Dis. 2018 May-Jun;22(3):193\u2013201. https:\/\/doi.org\/10.1016\/j.bjid.2018.05.001","DOI":"10.1016\/j.bjid.2018.05.001"},{"issue":"3","key":"12083_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.xkme.2021.01.012","volume":"3","author":"SB Ascher","year":"2021","unstructured":"Ascher SB, Scherzer R, Estrella MM, et al. Urine biomarkers of kidney tubule health and incident CKD stage 3 in women living with HIV: A repeated measures study. Kidney Med. 2021;3(3):395\u2013e4041. https:\/\/doi.org\/10.1016\/j.xkme.2021.01.012.","journal-title":"Kidney Med"},{"issue":"5","key":"12083_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000502898","volume":"50","author":"SB Ascher","year":"2019","unstructured":"Ascher SB, Scherzer R, Estrella MM, et al. Associations of urine biomarkers with kidney function decline in HIV-Infected and uninfected men. Am J Nephrol. 2019;50(5):401\u201310. https:\/\/doi.org\/10.1159\/000502898.","journal-title":"Am J Nephrol"},{"key":"12083_CR31","doi-asserted-by":"publisher","unstructured":"Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2021;99(1):34\u201347. https:\/\/doi.org\/10.1016\/j.kint.2020.10.012.","DOI":"10.1016\/j.kint.2020.10.012"},{"issue":"6","key":"12083_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/QAD.0000000000003839","volume":"38","author":"KA Edrosolan","year":"2024","unstructured":"Edrosolan KA, Shlipak MG, Scherzer R, Estrella MM, Gustafson D, Karim R, Fisher M, Cohen M, Kassaye S, Dumond J, Abraham A, McCulloch CE. Ascher.Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV. SB AIDS. 2024;38(6):813\u201324. https:\/\/doi.org\/10.1097\/QAD.0000000000003839. Epub 2024 Jan 12.","journal-title":"SB AIDS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12083-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12083-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12083-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:20:48Z","timestamp":1767054048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12083-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12083"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12083-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7373190\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. This is a retrospective study approved by the Ethics and Research Committee of the Hospital Clinic de Barcelona, Spain [HCB\/2020\/0662]. The Committee considered that patients did not need to sign an informed consent form, as the data were obtained from the existing laboratory information system, without requiring any additional sample collection. In addition, this study did not involve any interference with the routine clinical practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1812"}}